Patient Education in Preventing Nausea and Vomiting in Cancer Patients Receiving Chemotherapy

Completed · Not applicable

Conditions studied: Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific

In brief

RATIONALE: Patient education may improve the effectiveness of ondansetron in preventing nausea and vomiting in patients receiving chemotherapy. PURPOSE: This randomized clinical trial is studying how well patient education works in preventing nausea and vomiting in cancer patients receiving chemotherapy.

Key facts

Study ID

NCT00005994

Run by

University of Rochester

Starts

2000-08-01

Expected to finish

2001-07-01

Last updated by the study team

2013-03-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Hackensack University Medical Center — Hackensack, New Jersey, United States
• University of Rochester Cancer Center — Rochester, New York, United States
• CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C. — Syracuse, New York, United States
• CCOP - Southeast Cancer Control Consortium — Winston-Salem, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.